openPR Logo

Press Releases from Growth Hormone Deficiency Therapeutics- Pharma Proff (1 total)

Growth Hormone Deficiency Therapeutics- Pipeline Analysis 2018 | Novo Nordisk

Growth hormone deficiency is a congenital or acquired hormonal disorder, that is characterized by short stature due to lack of growth hormone. The disease can cause change in muscle mass, bone strengths, and cholesterol levels. Download the sample report @ This condition is found to be related to the mutation in POU1F1/Pit1, PROP1 GHRH and GH1 genes. Puberty is generally delayed or absent in adolescents with growth hormone deficiency. Get the

Go To Page:   1 2 3 4 5 6 7 8 9 10